Topsail Wealth Management LLC Makes New Investment in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Topsail Wealth Management LLC acquired a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm acquired 556 shares of the medical equipment provider's stock, valued at approximately $290,000.

Several other institutional investors have also recently bought and sold shares of the business. M.E. Allison & CO. Inc. acquired a new position in shares of Intuitive Surgical in the fourth quarter valued at approximately $449,000. Seilern Investment Management Ltd bought a new stake in shares of Intuitive Surgical in the fourth quarter worth $82,517,000. Sycomore Asset Management increased its holdings in Intuitive Surgical by 27.4% in the fourth quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider's stock valued at $9,214,000 after purchasing an additional 4,079 shares during the period. Exome Asset Management LLC raised its holdings in Intuitive Surgical by 16.8% during the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider's stock worth $3,649,000 after purchasing an additional 1,069 shares during the last quarter. Finally, China Universal Asset Management Co. Ltd. lifted its position in shares of Intuitive Surgical by 5.6% in the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider's stock worth $5,138,000 after purchasing an additional 525 shares during the period. Institutional investors and hedge funds own 83.64% of the company's stock.

Intuitive Surgical Trading Down 1.1 %

Shares of NASDAQ:ISRG traded down $5.87 during midday trading on Wednesday, reaching $509.02. The company had a trading volume of 482,407 shares, compared to its average volume of 1,613,055. The stock has a market cap of $182.44 billion, a P/E ratio of 79.41, a P/E/G ratio of 5.85 and a beta of 1.55. The company's 50 day moving average price is $508.20 and its 200 day moving average price is $533.13. Intuitive Surgical, Inc. has a 52-week low of $367.39 and a 52-week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. The firm had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. During the same period in the prior year, the firm earned $1.50 EPS. Research analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, EVP Robert Desantis sold 188 shares of the stock in a transaction on Monday, April 28th. The stock was sold at an average price of $515.91, for a total transaction of $96,991.08. Following the sale, the executive vice president now owns 5,224 shares in the company, valued at $2,695,113.84. This represents a 3.47 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Jamie Samath sold 269 shares of Intuitive Surgical stock in a transaction on Monday, February 10th. The shares were sold at an average price of $590.00, for a total value of $158,710.00. Following the completion of the transaction, the chief financial officer now owns 3,282 shares of the company's stock, valued at approximately $1,936,380. This trade represents a 7.58 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 30,913 shares of company stock worth $15,981,143. 0.70% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of analysts have weighed in on ISRG shares. CICC Research initiated coverage on Intuitive Surgical in a report on Monday, January 27th. They set a "neutral" rating and a $550.00 price target for the company. JPMorgan Chase & Co. raised their price objective on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an "overweight" rating in a research report on Friday, January 24th. BTIG Research set a $560.00 target price on shares of Intuitive Surgical and gave the company a "buy" rating in a research report on Monday, April 14th. Royal Bank of Canada dropped their price objective on shares of Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a report on Wednesday, April 23rd. Finally, Barclays reduced their target price on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating for the company in a research note on Thursday, April 24th. Five equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $598.95.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.